BioAdvance News

QR Pharma Initiates Clinical Trial for Cognitively Impaired Patients

By WebmasterFebruary 10, 2010November 1st, 2024No Comments

QR Pharma Initiates Clinical Trial for Cognitively Impaired Patients
Read more here

Previous PostQR Pharma Receives US Patent 7,625,942 to Treat Down Syndrome
Next PostTreventis Scientific Founder Named 2009 Recipient of Prix Galien Canada Award for Alzheimer’s Disease